Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

A new method accurately measures nine specific hormones in human blood.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

COVID-19 doesn't make alopecia areata worse.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Anionic surfactants significantly improve the foaming of minoxidil gel shampoo.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Keratin from hair binds well to gold and BMP-2, useful for bone repair.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The updated SALT II tool offers a more precise way to measure scalp hair loss.